{
    "clinical_study": {
        "@rank": "161433", 
        "arm_group": [
            {
                "arm_group_label": "nutrition intervention", 
                "arm_group_type": "Active Comparator", 
                "description": "high protein diet"
            }, 
            {
                "arm_group_label": "control diet", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators aimed to determine the effects of HP diet on adiponectin and inflammatory\n      factors among overweight and obese children."
        }, 
        "brief_title": "Effect of High Protein Diet on Adiponectin and Inflammation Among Overweight and Obese Children", 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Body Mass Index Quantitative Trait Locus 5 Disorder", 
            "Tangier Disease"
        ], 
        "condition_browse": {
            "mesh_term": "Tangier Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  BMI > 85th\n\n          -  age of 6-11 years\n\n          -  no history of chronic diseases\n\n          -  taken medications\n\n        Exclusion Criteria:\n\n          -  do not prescribe their diet\n\n          -  mental retardation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "11 Years", 
            "minimum_age": "6 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01886495", 
            "org_study_id": "high protein diet in children"
        }, 
        "intervention": {
            "arm_group_label": "nutrition intervention", 
            "intervention_name": "nutrition intervention", 
            "intervention_type": "Other", 
            "other_name": "high protein diet"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 25, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Isfahan", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Isfahan University of Medical Sciences Leila Azadbakht, Phd"
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "High Protein Diet , Adiponectin and Inflammatory Factors", 
        "overall_official": {
            "affiliation": "Isfahan University of Medical Sciences", 
            "last_name": "Leila Azadbakht, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "December 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "amount of adiponectin", 
            "measure": "adiponectin (mcg/ml)", 
            "safety_issue": "Yes", 
            "time_frame": "10 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01886495"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Isfahan University of Medical Sciences", 
            "investigator_full_name": "Leila Azadbakht", 
            "investigator_title": "Isfahan University of Medical Sciences", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "interlukine 6 (mcg/ml)", 
                "safety_issue": "Yes", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "tumor necrosis factor alpha (ng/ml)", 
                "safety_issue": "Yes", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "C reactive protein (mcg/ml)", 
                "safety_issue": "Yes", 
                "time_frame": "10 weeks"
            }, 
            {
                "measure": "fibrinogen (mcg/ml)", 
                "safety_issue": "Yes", 
                "time_frame": "10 weeks"
            }
        ], 
        "source": "Isfahan University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isfahan University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}